KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) EBT Margin (2020 - 2026)

Organon has reported EBT Margin over the past 7 years, most recently at 14.59% for Q1 2026.

  • For Q1 2026, EBT Margin rose 791.0% year-over-year to 14.59%; the TTM value through Mar 2026 reached 8.71%, down 196.0%, while the annual FY2025 figure was 6.84%, 577.0% down from the prior year.
  • EBT Margin for Q1 2026 was 14.59% at Organon, up from 9.82% in the prior quarter.
  • Over five years, EBT Margin peaked at 37.85% in Q4 2022 and troughed at 9.82% in Q4 2025.
  • A 5-year average of 13.92% and a median of 14.59% in 2026 define the central range for EBT Margin.
  • Biggest five-year swings in EBT Margin: skyrocketed 2312bps in 2022 and later tumbled -3134bps in 2023.
  • Year by year, EBT Margin stood at 37.85% in 2022, then tumbled by -83bps to 6.51% in 2023, then rose by 25bps to 8.1% in 2024, then crashed by -221bps to 9.82% in 2025, then soared by 249bps to 14.59% in 2026.
  • Business Quant data shows EBT Margin for OGN at 14.59% in Q1 2026, 9.82% in Q4 2025, and 15.17% in Q3 2025.